aquascoot
|
Aclass action, organised and crowd-funded by Queensland GP Dr Melissa McCann, is taking aim at the Commonwealth government and the Therapeutic Goods Administration (TGA), along with a number of senior public servants, alleging negligence, breach of statutory duty and misfeasance in public office.
The suit alleges that the respondents approved the vaccines “with no proper or reasonable evidentiary or logical basis to reasonably determine the vaccines to be safe, effective and possessing a positive risk-benefit profile.”
As the public was inundated with government messaging and coercive tactics, such as mandates and the exclusion from society, little information was disclosed about the potential risks of the trial therapeutic that neither stopped transmission or infection.
The existing Commonwealth compensation scheme open to Australians who ‘suffer a moderate to severe impact following an adverse reaction to a TGA-approved Covid-19 vaccine’, has received 3,501 applications and paid 137 claims. Another 2,263 claims are still in progress, while 405 have been withdrawn and 696 deemed not payable.
The nation-wide suit, which reportedly has 500 members, including three named applicants, seeks redress for those allegedly left injured or bereaved by the Covid-19 vaccines. One of the applicants, who suffered a severe heart condition after getting the Pfizer jab is even claiming there was ‘cover-up’ during the vaccine rollout, which hid the potential risks.
Recently, a report released under freedom of information demonstrated the Australian Therapeutic Goods Administration had information since January 2021 that the distribution of the lipid nanoparticle, which delivers the mRNA, did not stay in the injection site as claimed throughout the vaccine rollout.
A 2022 re-analyse of the Pfizer and Moderna trial data by the Medical Journal Vaccine (authors Joseph Fraiman, ER doctor and clinical data scientist; Dr Peter Doshi, Associate Editor of British medical journal; Dr Robert Kaplan from Stanford) found that in the trials that led to the approval by the regulators, you are more likely to suffer a serious adverse event from taking the vaccine than you were to be hospitalised with Covid-19. The rate of serious adverse events found by the authors was 1 in 800.
|